Skip to main content

Epilepsy Research

Where investment meets impact

From lab discovery to brain health innovation

A Brain Canada Platform Support Grant enabled Dr. Deborah Kurrasch (University of Calgary) to develop MitoREAD, a patented drug discovery technology targeting mitochondrial dysfunction — found consistently across epilepsy, ALS, autism, and more — spawning two spin-off companies and millions in follow-on funding.

Read the full story

Approximately 65 million people worldwide are affected by epilepsy – a debilitating neurological disorder. Brain Canada-funded researchers are committed to finding better solutions for those touched by the disorder, including patients who suffer from a drug-resistant form of the disease.

Donate

Our Projects

Brain Canada’s rigorous scientific review process gives donors and partners a trusted mechanism to ensure projects are chosen based on merit, innovation, and potential for impact.

Search the directory

$5,194,027
invested

10
grants awarded

Our Partners

Making a significant difference in the lives of people in Canada doesn’t happen in a vacuum. It takes a network of visionary partners committed to investing in change. As a national convenor and facilitator, Brain Canada works with partners from coast to coast to drive innovative brain research. Some of our partners in supporting epilepsy research include:

See all our partners